Twist Bioscience Corporation (NASDAQ: TWST) reported Q3 EPS of ($0.82), $0.07 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $35 million versus the consensus estimate of $32.27 million.

GUIDANCE:

Twist Bioscience Corporation sees FY2021 revenue of $129-132 million, versus the consensus of $127 million.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.